Immunoassay Market - Global Forecast 2025-2032

The Immunoassay Market is rapidly evolving, providing essential solutions that underpin diagnostics, healthcare innovation, and biomedical research. Senior decision-makers seeking to optimize strategies and capture emerging opportunities require precise, actionable market intelligence to navigate this dynamic environment.

Market Snapshot: Immunoassay Market Growth and Outlook

The global Immunoassay Market advanced from USD 28.29 billion in 2024 to USD 30.38 billion in 2025, and is forecast to propel further at a CAGR of 7.37%, reaching USD 49.98 billion by 2032. This growth trajectory highlights transformative industry shifts fueled by technological innovation, regulatory change, and the need for advanced diagnostic platforms across clinical and research settings.

Scope & Segmentation

• Type: Qualitative Immunoassays, Quantitative Immunoassays
• Technology: Enzyme Immunoassays, Enzyme-Linked Immunosorbent Assay, Fluorescent Immunoassay, Lateral Flow Assay, Radioimmunoassay, Western Blot
• Instruments: Analyzers & Kits, Biosensors, Microfluidic Devices, Microplates, PCR Devices, Reagents (including Antibodies, Antigens, Blocking Reagents, Buffers & Standards, Enzymes, Substrates), Software & Services
• Sample Types: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples
• Detection Modes: Chemiluminescent, Colorimetric, Fluorometric, Radioisotopic
• Application Areas: Allergy, Autoimmune Diseases, Cardiology, Endocrinology, Infectious Diseases, Oncology, Toxicology (Drug Screening, Environmental Testing)
• End Users: Contract Research Organizations, Diagnostic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research Institutions
• Deployment Types: Laboratory Tests, Point-of-care Test
• Regional Coverage: Americas (including North America: United States, Canada, Mexico; Latin America: Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (incorporating United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Key Players: Abbott Laboratories, Agilent Technologies Inc., Almac Group Limited, ANP Technologies, Inc., Autobio Diagnostics Co., Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc., bioMérieux S.A., Biosurfit SA, Boditech Med Inc., Charles River Laboratories International, Inc., Danaher Corporation, Diasorin S.p.A., Dynex Technologies, Inc., Epitope Diagnostics Inc., F. Hoffmann-La Roche Ltd., Fapon Biotech Inc., Gyros Protein Technologies AB by Mesa Laboratories, Inc., H.U. Group Holdings Inc., J. Mitra & Co. Pvt. Ltd., Kamiya Biomedical Company, Koninklijke Philips N.V., Merck KGaA, MiCo BioMed, Inc., NanoEntek, Nanōmix, Inc., OPKO Health, Inc., Promega Corporation, QIAGEN N.V., Quanterix Corporation, QuidelOrtho Corporation, Randox Laboratories Ltd., Revvity, Inc. (Formally PerkinElmer, Inc.), Sekisui Diagnostics, LLC, Shenzhen Micropoint Biotechnologies Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Sysmex Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Tosoh Corporation, WAK-Chemie Medical GmbH, Zoetis Inc., Zybio Inc.

Key Takeaways

• Immunoassay advancements are transitioning from manual to highly automated, data-integrated platforms, facilitating wider adoption in both central labs and point-of-care environments.
• Sophisticated technologies like microfluidics and multiplexing are reducing assay times and sample requirements, enabling comprehensive testing from minimal patient samples.
• Digital and AI-driven analytics are becoming integral to workflows, supporting improved patient stratification and enhancing the precision of diagnostic outputs for personalized medicine strategies.
• Segment dynamics show increasing diversity—from traditional enzyme immunoassays to lateral flow and biosensor formats—addressing both established and emerging needs across broad clinical specialties.
• Regionally, strong infrastructure and reimbursement strategies drive innovation uptake in the Americas, whereas emerging Asia-Pacific and EMEA markets are scaling capacity and expanding local technology partnerships.
• Leading players are leveraging innovation in reagents and analyzer platforms, while forging strategic alliances for greater market access and responsive service models.

Tariff Impact: Navigating 2025 Trade Dynamics

Recent United States tariff policies on immunoassay instruments and consumables have influenced supply chain and procurement strategies. Organizations are implementing dual sourcing and investing in domestic production where feasible. Such approaches enhance flexibility and reduce exposure to policy-driven cost fluctuations, empowering stakeholders to maintain stable supply channels and foster customer trust despite regulatory uncertainty.

Methodology & Data Sources

This analysis draws on an extensive multi-phase process including secondary research, direct interviews with industry leaders, and triangulation of quantitative market indicators. Rigorous validation—comprising peer review and scenario testing—ensures findings are accurate and decision-ready for strategic planning.

Why This Report Matters

• Supports strategic decisions by highlighting actionable growth opportunities and risk mitigation strategies in the immunoassay sector.
• Delivers clarity on evolving technology trends, regional market forces, and shifting procurement scenarios essential for competitive positioning.
• Equips leaders to anticipate key inflection points and focus investment where innovation will have the strongest market impact.

Conclusion

Innovation, operational agility, and strategic partnerships remain central to capitalizing on Immunoassay Market opportunities. Stakeholders prioritizing diversified sourcing, integrated analytics, and collaborative growth models will be best positioned for future market leadership.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.